| lineage | Count |
|---|---|
| lineage2.2.1.1 | 6 |
| lineage2.2.1 | 28 |
| lineage4.3.3 | 2 |
| lineage2.2;lineage4.2.2;lineage4.4 | 1 |
| lineage1.2.2.2 | 1 |
| spoligotype | Count |
|---|---|
| None | 38 |
| ID | Drug resistance | Lineage | Country iso2 | SRR21576592 | MDR-TB | lineage2.2.1.1 | None | SRR21746994 | MDR-TB | lineage2.2.1 | None | ERR7737763 | MDR-TB | lineage2.2.1 | None | ERR5865855 | Pre-XDR-TB | lineage2.2.1 | None | ERR5865856 | Pre-XDR-TB | lineage2.2.1 | None | SRR11662434 | Pre-XDR-TB | lineage2.2.1 | None | ERR13261676 | Pre-XDR-TB | lineage4.3.3 | None | ERR4872344 | XDR-TB | lineage2.2.1 | None | SRR20969900 | Pre-XDR-TB | lineage2.2.1.1 | None | ERR4813467 | MDR-TB | lineage4.3.3 | pe | ERR8975713 | Pre-XDR-TB | lineage2.2.1 | None | SRR5710016 | Pre-XDR-TB | lineage2.2.1.1 | th | SRR5709928 | Pre-XDR-TB | lineage2.2.1 | th | SRR8217894 | Pre-XDR-TB | lineage2.2.1 | None | SRR21576540 | Pre-XDR-TB | lineage2.2.1 | None | ERR3794366 | Pre-XDR-TB | lineage2.2.1 | None | SRR30180274 | MDR-TB | lineage2.2.1 | None | SRR671761 | Pre-XDR-TB | lineage2.2.1.1 | cn | SRR27069386 | Pre-XDR-TB | lineage2.2.1 | None | ERR13284282 | Pre-XDR-TB | lineage2.2.1 | None | ERR502892 | MDR-TB | lineage2.2.1 | None | SRR23691410 | MDR-TB | lineage2.2.1 | None | SRR6832418 | MDR-TB | lineage2.2.1 | None | ERR4830058 | Pre-XDR-TB | lineage2.2.1 | None | SRR24256346 | MDR-TB | lineage2.2.1 | None | SRR18002873 | Pre-XDR-TB | lineage2.2;lineage4.2.2;lineage4.4 | None | SRR6832260 | RR-TB | lineage2.2.1 | None | SRR29539680 | Pre-XDR-TB | lineage2.2.1 | None | ERR1063861 | MDR-TB | lineage1.2.2.2 | None | ERR5918037 | Pre-XDR-TB | lineage2.2.1 | za | SRR5709823 | Pre-XDR-TB | lineage2.2.1 | th | ERR1035100 | Pre-XDR-TB | lineage2.2.1.1 | vn | ERR13290717 | Pre-XDR-TB | lineage2.2.1 | None | ERR13291136 | MDR-TB | lineage2.2.1.1 | None | SRR11662655 | MDR-TB | lineage2.2.1 | None | SRR3205962 | Pre-XDR-TB | lineage2.2.1 | None | SRR14807466 | XDR-TB | lineage2.2.1 | None | ERR11081275 | Pre-XDR-TB | lineage2.2.1 | None |
|---|